The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 12, 2019
Filed:
Dec. 23, 2016
Applicant:
Tufts University, Boston, MA (US);
Inventors:
Noorjahan Panjwani, Medford, MA (US);
Wei-Sheng Chen, Kaohsiung, TW;
Assignee:
Tufts University, Boston, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 38/47 (2006.01); G01N 33/68 (2006.01); A61K 31/702 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1732 (2013.01); A61K 31/702 (2013.01); A61K 38/47 (2013.01); C12Y 302/02029 (2013.01); G01N 33/6893 (2013.01); G01N 2333/4724 (2013.01); G01N 2333/912 (2013.01); G01N 2800/52 (2013.01);
Abstract
Compositions and methods are provided for treating and/or preventing lymphangiogenesis in a subject by using an inhibitor of a galectin-8 protein in an amount effective to inhibit or to modulate an activity of the galectin-8 protein or a portion thereof sufficient to inhibit the lymphangiogenesis associated with cancer, corneal injury, dry eye disease, inflammation, lymphedema, organ rejection or graft rejection.
Quick Actions:
Panjwani, Noorjahan. (2019). Lymphangiogenesis inhibitors for cancer and for graft survival (U.S. Patent No. 10226509). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10226509
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile